The European Partnership for Personalised Medicine (EP PerMed) is a Horizon Europe-funded initiative (launched in Nov 2023) that coordinates research, innovation, and implementation across Europe to accelerate personalised medicine. It brings together national/regional funding bodies, ministries, healthcare providers, industry, researchers, and patients to support the full “value continuum” — from basic research to clinical pilots and health system uptake.
Key goals include:
- Translating scientific discoveries into patient-centred applications
- Integrating big data, digital health, and omics technologies
- Strengthening health systems’ capacity to adopt personalised approaches
- Demonstrating the value (clinical, societal, economic) of personalised medicine for sustainable healthcare
To steer its work, EP PerMed follows a Strategic Research & Innovation Agenda (SRIA) that defines priorities and supports joint calls, pilot projects, capacity building, and policy dialogue.
Open Calls
no updates
